Okumura K, Ohkura N, Inoue S, Ikeda K, Hayashi K
Department of Biochemistry, Osaka University of Pharmaceutical Sciences, Nasahara, Takatsuki, Osaka 569-1094, Japan.
J Biol Chem. 1998 Jul 31;273(31):19469-75. doi: 10.1074/jbc.273.31.19469.
The phospholipase A2 (PLA2) inhibitor PLIbeta, purified from the blood plasma of Chinese mamushi snake (Agkistrodon blomhoffii siniticus), is a 160-kDa trimer with three 50-kDa subunits; and it inhibits specifically the enzymatic activity of the basic PLA2 from its own venom (Ohkura, N., Okuhara, H., Inoue, S., Ikeda, K., and Hayashi, K. (1997) Biochem. J. 325, 527-531). In the present study, the 50-kDa subunit was found to be glycosylated with N-linked carbohydrate, and enzymatic deglycosylation decreased the molecular mass of the 50-kDa subunit to 39-kDa. One 160-kDa trimer of PLIbeta was found to form a stable complex with three basic PLA2 molecules, indicating that one basic PLA2 molecule would bind stoichiometrically to one subunit of PLIbeta. A cDNA encoding PLIbeta was isolated from a Chinese mamushi liver cDNA library by use of a probe prepared by a polymerase chain reaction on the basis of the partially determined amino acid sequence of the subunit. The cDNA contained an open reading frame encoding a 23-residue signal sequence followed by a 308-residue protein, which contained the sequences of all the peptides derived by lysyl endopeptidase digestion of the subunit. The molecular mass of the mature protein was calculated to be 34,594 Da, and the deduced amino acid sequence contained four potential N-glycosylation sites. The sequence of PLIbeta showed no significant homology with that of the known PLA2 inhibitors. But, interestingly, it exhibited 33% identity with that of human leucine-rich alpha2-glycoprotein, a serum protein of unknown function. The most striking feature of the sequence is that it contained nine leucine-rich repeats (LRRs), each of 24 amino acid residues and thus encompassing over two-thirds of the molecule. LRRs in PLIbeta might be responsible for the specific binding to basic PLA2, since LRRs are considered as the motifs involved in protein-protein interactions.
从中国蝮蛇(Agkistrodon blomhoffii siniticus)血浆中纯化得到的磷脂酶A2(PLA2)抑制剂PLIβ是一种160 kDa的三聚体,由三个50 kDa的亚基组成;它能特异性抑制自身毒液中碱性PLA2的酶活性(Ohkura, N., Okuhara, H., Inoue, S., Ikeda, K., and Hayashi, K. (1997) Biochem. J. 325, 527 - 531)。在本研究中,发现50 kDa的亚基被N - 连接碳水化合物糖基化,酶促去糖基化使50 kDa亚基的分子量降至39 kDa。一个PLIβ的160 kDa三聚体被发现与三个碱性PLA2分子形成稳定复合物,这表明一个碱性PLA2分子将按化学计量比与PLIβ的一个亚基结合。基于亚基部分测定的氨基酸序列,通过聚合酶链反应制备探针,从中国蝮蛇肝脏cDNA文库中分离出编码PLIβ的cDNA。该cDNA包含一个开放阅读框,编码一个23个残基的信号序列,随后是一个308个残基的蛋白质,其中包含通过赖氨酸内肽酶消化亚基得到的所有肽段的序列。成熟蛋白的分子量经计算为34,594 Da,推导的氨基酸序列包含四个潜在的N - 糖基化位点。PLIβ的序列与已知的PLA2抑制剂序列无明显同源性。但有趣的是,它与人类富含亮氨酸的α2 - 糖蛋白(一种功能未知的血清蛋白)的序列有33%的同一性。该序列最显著的特征是它包含九个富含亮氨酸的重复序列(LRR),每个重复序列由24个氨基酸残基组成,因此涵盖了分子的三分之二以上。PLIβ中的LRR可能负责与碱性PLA2的特异性结合,因为LRR被认为是参与蛋白质 - 蛋白质相互作用的基序。